Ftse Mib
34.465,68
-0,40%
DAX
18.680,20
-0,25%
S&P 500
5.318,73
-0,05%
NASDAQ
16.830,01
-0,02%
Bitcoin
70.246,19
0,16%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Roquefort Therapeutics Plc (ROQ) Roquefort Therapeutics Plc (ROQ) Notizie

ROQ

Roquefort Therapeutics (ROQ)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:ROQ
DataOraFonteTitoloSimboloCompagnia
26/04/202421:59Alliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
26/04/202408:00RNS Regulatory NewsRoquefort Therapeutics PLC Annual Report & Financial Statements - 31 Dec 2023LSE:ROQRoquefort Therapeutics Plc
05/04/202413:32Alliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
05/04/202408:00RNS Regulatory NewsRoquefort Therapeutics PLC Response to Share Price MovementLSE:ROQRoquefort Therapeutics Plc
11/03/202412:12Alliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
11/03/202408:00RNS Regulatory NewsRoquefort Therapeutics PLC Positive Results: Midkine mRNA and STAT-6 siRNALSE:ROQRoquefort Therapeutics Plc
06/02/202417:50Alliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
06/02/202408:00RNS Regulatory NewsRoquefort Therapeutics PLC Operations UpdateLSE:ROQRoquefort Therapeutics Plc
24/11/202308:00UK RegulatoryRoquefort Therapeutics PLC Change of AuditorLSE:ROQRoquefort Therapeutics Plc
06/11/202313:01Alliance NewsAlliance NewsRoquefort Therapeutics MK cell programme shows positive resultsLSE:ROQRoquefort Therapeutics Plc
06/11/202308:00UK RegulatoryRoquefort Therapeutics PLC Significant Mesodermal Killer Cell MilestoneLSE:ROQRoquefort Therapeutics Plc
27/09/202316:43Alliance NewsAlliance NewsEARNINGS: Biome loss widens; Amicorp focused on growth post-IPOLSE:ROQRoquefort Therapeutics Plc
27/09/202308:00UK RegulatoryRoquefort Therapeutics PLC Interim Results to 30 June 2023LSE:ROQRoquefort Therapeutics Plc
22/09/202312:42RNS Non-RegulatoryRoquefort Therapeutics PLC Investor Presentation via Investor Meet CompanyLSE:ROQRoquefort Therapeutics Plc
14/08/202312:07Alliance NewsAlliance NewsRoquefort files patent application for mRNA and RNA therapiesLSE:ROQRoquefort Therapeutics Plc
14/08/202308:00UK RegulatoryRoquefort Therapeutics PLC Expansion of Patent PortfolioLSE:ROQRoquefort Therapeutics Plc
07/08/202312:04Alliance NewsAlliance NewsIN BRIEF: Roquefort announces new sirNA sequences and patent filingLSE:ROQRoquefort Therapeutics Plc
07/08/202308:00UK RegulatoryRoquefort Therapeutics PLC Development of New Novel siRNA TherapeuticsLSE:ROQRoquefort Therapeutics Plc
02/08/202308:00UK RegulatoryRoquefort Therapeutics PLC Director/PDMR ShareholdingLSE:ROQRoquefort Therapeutics Plc
29/06/202319:51Alliance NewsAlliance NewsTRADING UPDATES: Anpario trading in line, Likewise Group sales riseLSE:ROQRoquefort Therapeutics Plc
29/06/202311:05UK RegulatoryRoquefort Therapeutics PLC Results of AGMLSE:ROQRoquefort Therapeutics Plc
29/06/202308:00UK RegulatoryRoquefort Therapeutics PLC AGM StatementLSE:ROQRoquefort Therapeutics Plc
22/06/202321:34Alliance NewsAlliance NewsTRADING UPDATES: Plant Health Care announces GBP2.8 million fundraiseLSE:ROQRoquefort Therapeutics Plc
22/06/202308:00UK RegulatoryRoquefort Therapeutics PLC RNA Medicine Shows In Vitro Anti-Cancer EfficacyLSE:ROQRoquefort Therapeutics Plc
19/06/202313:28Alliance NewsAlliance NewsRoquefort Therapeutics celebrates cancer antibody trial resultsLSE:ROQRoquefort Therapeutics Plc
19/06/202308:00UK RegulatoryRoquefort Therapeutics PLC Antibody Program Results & Orphan Drug IndicationLSE:ROQRoquefort Therapeutics Plc
13/06/202312:52Alliance NewsAlliance NewsIN BRIEF: Roquefort says anti-cancer mRNA study shows positive resultsLSE:ROQRoquefort Therapeutics Plc
13/06/202308:00UK RegulatoryRoquefort Therapeutics PLC Anti-Cancer MDK mRNA - Positive in vitro ResultsLSE:ROQRoquefort Therapeutics Plc
07/06/202315:41Alliance NewsAlliance NewsIN BRIEF: Roquefort Therapeutics suspension on shares liftedLSE:ROQRoquefort Therapeutics Plc
07/06/202311:11UK RegulatoryRoquefort Therapeutics PLC Restoration of TradingLSE:ROQRoquefort Therapeutics Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:ROQ

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network